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Impaired IgG-Dependent Anaphylaxis
and Arthus Reaction in
FcgRIII (CD16) Deficient Mice
Wouter L. W. Hazenbos,* J. Engelbert Gessner,‡ analyses three classes of leukocyte FcgR can be distin-
guished, i.e., FcgRI (CD64), FcgRII (CD32), and FcgRIIIFrans M. A. Hofhuis,* Henri Kuipers,*
Dirk Meyer,‡ Ingmar A. F. M. Heijnen,* (CD16) (Ravetch and Kinet, 1991; Van de Winkel and
Capel, 1993). Extensive in vitro studies, the majority ofReinhold E. Schmidt,‡ Matyas Sandor,§
Peter J. A. Capel,* Marc Dae¨ron,† which used transfected cell lines, have shown that
FcgRs trigger various effector functions such as phago-Jan G. J. van de Winkel,* and J. Sjef Verbeek*
*Department of Immunology cytosis, release of reactive oxygen metabolites, degran-
ulation, and enhancement of antigen presentation (re-University Hospital Utrecht
Post Office Box 85500 viewed by Ravetch and Kinet, 1991; Van de Winkel and
Capel, 1996). In addition, certain FcgRII isoforms can3508 GA
Utrecht exert down-regulatory effects including inhibition of sur-
face immunoglobulin–induced B cell activation (PhilipsThe Netherlands
†Laboratoire d’Immunologie Cellulaire et Clinique and Parker, 1984) and of FceRI-mediated mast cell acti-
vation (Dae¨ron et al., 1995a; Takai et al., 1996). TheInstitut National de la Sante´ et de la Recherche
Me´dicale U.255 contribution of the different FcgR classes to the in vivo
immune response is difficult to dissect for the followingInstitut Curie
26 Rue D’Ulm reasons: most leukocytes coexpress several FcgR iso-
forms; the different FcgRs show overlapping binding75005 Paris
France patterns for the four IgG subclasses; FcgRI and FcgRIII
share a signal transduction subunit, the FcR g chain (Ra‡Department of Clinical Immunology
Medical School et al., 1989; Ernst et al.,1993; Hibbset al.,1989), together
with the high affinity FcR for IgE (Blank et al., 1989) andKonstanty Gutschow Strasse 8
30625 Hannover IgA (Morton et al., 1995); complement and FcgR act
synergistically in various IgG-dependent effector cellFederal Republic of Germany
§Pathology and Lab Medicine functions (Jones and Brown, 1996). Two recently de-
scribed knockout mouse models addressed this prob-University of Wisconsin
Madison, Wisconsin 53706 lem. FcgRII-deficient mice showed augmented humoral
and anaphylactic responses (Takai et al., 1996), confirm-
ing the down-modulatory function of this receptor sug-
gested earlier (Dae¨ron et al., 1995b). FcR g chain2/2 miceSummary
suggested a central role for FcgR in initiating the immune
complex–mediated inflammatory response (SylvestreThe family of receptors for IgG (FcgR) plays an essen-
and Ravetch, 1994). However, since g chain2/2 mice lacktial role in antibody-mediated effector functions of the
multiple FcR, the specific FcgR classes involved in in-immune system. However, the specific contribution of
flammation could not be identified. FcR g chain2/2 miceeach of the FcgR classes to in vivo immune reactions
also exhibited an impaired IgE-dependent anaphylaxisis still unclear. Here, we demonstrate that mice defi-
(Takai et al., 1994), confirming earlier results using FceRIcient for the ligand-binding a chain of FcgRIII lack NK
a chain2/2 deficient mice (Dombrowicz et al., 1993). Thecell–mediated antibody-dependent cytotoxicity and
role of FcR in IgG-dependent anaphylaxis as yet remainsphagocytosis of IgG1-coated particles by macro-
to be clarified. Here, we identify FcgRIII as the essentialphages.Strikingly, these mice lack IgG-mediated mast
FcgR mediating IgG-dependent passive cutaneous ana-cell degranulation, are resistant to IgG-dependent
phylaxis and reverse passive Arthus reaction using micepassive cutaneous anaphylaxis, and exhibit an im-
deficient for the ligand-binding a chain of this receptor.paired Arthus reaction. These results indicate a promi-
nent role for FcgRIII in inflammatory and anaphylactic
responses, making this receptor a potential target in Results and Discussion
immunotherapy.
Generation of FcgRIII-Deficient Mice
A gene-targeting construct was generated (Verbeek et
al., 1995) in which both the ligand-binding EC2 domainIntroduction
and part of the transmembrane region were replaced
by the hygromycin resistance gene (Figure 1A). The con-Immunoglobulin receptors (FcR), which are expressed
on a wide variety of hematopoeitic cells, link cellular and struct was electroporated into E14 embryonic stem (ES)
cells, the targeted ES clones injected into C57BL/6 blas-humoral immunity by bridging the antibody specificity to
effector cells. Cross-linking these receptors with anti- tocysts, and the resulting chimeras bred to C57BL/6
females. Southern blot analysis of tail DNA of agoutibody–antigen complexes activates intracellular signal
transduction resulting in various cellular responses. The pups showed transmission of the targeted allele (Figure
1B). Homozygous FcgRIII2/2 developed normally andreceptors for immunoglobulin G (IgG), FcgR, are en-
coded by a multigene family and exhibit structural he- were fertile. The absence of mRNA for FcgRIII was dem-
onstrated by RT–PCR (Figure 1C).terogeneity. Based on genetic and in vitro functional
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Figure 1. Targeted Disruption of the FcgRIII Gene
(A) Schematic representation of the murine FcgRIII wild-type gene (top), the targeting construct (middle), and the disrupted allele (bottom).
The exons (coding parts depicted in closed boxes, noncoding parts in open boxes) are marked in accordance to the functional domains they
encode: S1 and S2, signal peptide; EC1 and EC2, the extracellular immunoglobulin-like domains; TM/C, transmembrane-cytoplasmic tail
region. Restriction sites are as follows: BamHI (B), EcoRI (E), HindIII (H), KpnI (K), StuI (St).
(B) Southern blot analysis of EcoRI-digested genomic DNA from wild-type (1/1), heterozygous (1/2), and homozygous (2/2) mutant mice.
The blot was hybridized with a 39 flanking genomic probe indicated in (A). Hybridizing bands of 10 kb or 3.2 kb indicate the presence of
FcgRIII wild-type or FcgRIII mutant alleles, respectively.
(C) FcgRIII transcript analysis. RNA from NK cell fraction of splenocytes of two wild-type and two FcgRIII2/2 mice was analyzed by RT–PCR
using the sense primer S1s and the three distinct antisense primers EC1as, EC2as, and 3UTas (see Experimental Procedures for description
of the primers), resulting in the amplification of FcgRIII-specific fragments of 345, 606, and 785 bp in the wild type only.
(D) Flow cytometric analysis of wild-type and FcgRIII2/2 splenic NK cells, peripheral blood B lymphocytes, and resident peritoneal macrophages
stained with anti FcgRII/III MAb 2.4G2 and counterstained with the MAbs 4D11 (anti LGL-1, recognizing about 50% of NK cells), B220, and
Mac-1, respectively.
(E) Flow cytometric analysis of dispersed fetal (day 16.5) thymus of FcgRIII2/2 mice. Double-negative (CD42/CD82) cells (left) gated by their
low Thy1 staining were stained with anti-CD44 and anti-IL2R a chain antibodies to identify the different stages of pre-T cell development.
Double-negative (CD42/CD82), IL2Ra2, Thy1lo, CD441 cells stained positively with 2.4G2 (middle and right).
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The absence of FcgRIII surface expression was dem-
onstrated by flow cytometric analysis of natural killer
(NK) cells, which normally express FcgRIII only; B lym-
phocytes,which normallyexpress FcgRII only, and mac-
rophages; and neutrophils, which normally coexpress
FcgRII and FcgRIII, using the rat anti-FcgRII/III antibody
2.4G2. Staining with 2.4G2 was completely lost on
FcgRIII2/2 NK cells (Figure 1D), unaffected on B lympho-
cytes (Figure1D), and partially reduced onmacrophages
(Figure 1D) and neutrophils (data not shown). This con-
firmed that disruption of the FcgRIII gene resulted in the
lack of surface expression of FcgRIII and in unaffected
expression of FcgRII.
In spite of the proposed role for FcgRII, FcgRIII, or
both, in T cell and NK cell ontogeny (Rodewald et al.,
1992), the development of neither lymphoid nor myeloid
lineages was affected by the loss of FcgRIII as revealed
by flow cytometry of cells derived from thymus, spleen,
peritoneal cavity, peripheral blood, and bone marrow,
and by immunohistochemical analysis of gd T cells in
dermal sheets (Kuziel et al., 1991) (data not shown). A
fraction of pre-T cells in the fetal thymus of FcgRIII2/2
mice retain 2.4G2 staining, in a similar developmental
window as in wild-type mice, providing direct evidence
that FcgRII (CD32) is expressed on these cells (Fig-
ure 1E).
Antibody-Dependent Cell-Mediated
Cytotoxicity by NK Cells
In contrast with NK cells from wild-type mice, FcgRIII2/2
NK cells did not exhibit antibody-dependent cell-medi-
ated cytotoxicity (ADCC) activity against NK-resistant
L1210 tumor targets coated with polyclonal rabbit anti-
serum (Figure 2B). This result, confirmed by reverse
ADCC, using NK cells cultured with 2.4G2 and FcgR-
expressing L1210 tumor targets (Figure 2C), excludes
any possibility of other NK surface molecules substitut-
ing for FcgRIII in ADCC. NK activity against the YAC-1
tumor target was unaffected by disruption of the FcgRIII
gene (Figure 2A), confirming that receptors other than
FcgRIII mediate this process (Lanier and Philips, 1996).
Phagocytosis of IgG-Coated SRBCs
by Macrophages
Phagocytosis of IgG-opsonized sheep red blood cells
(SRBCs) was determined using thioglycolate-elicited Figure 2. NK and ADCC Activity by NK Cells
peritoneal macrophages that normally express FcgRI, Splenic NK cells from 1/1 (closed symbols) or 2/2 mice (open sym-
FcgRII, and FcgRIII. Unexpectedly, macrophages from bols) were incubated with (A) NK-susceptible 51Cr-labeled YAC-1
FcgRIII2/2 mice showed strongly diminished phagocyto- target cells to determine NK activity; with (B) 51Cr-labeled L1210 NK-
resistant target cells that were preincubated with specific polyclonalsis of IgG1-opsonized SRBCs. In marked contrast,
rabbit anti-L1210 antiserum (triangles) or medium (squares) to deter-phagocytosis of mouse IgG2a- and IgG2b-opsonized
mine ADCC; or with (C) 51Cr-labeled L1210 cells after preincubationSRBC was not affected (Figure 3A), demonstrating that
with 2.4G2 (triangles) or medium (squares) to determine reverse
the phagocytosis machinery remains functionally intact. ADCC. Shown are the mean values of triplicates (SD < 5%).
The apparent specificity of IgG1 for FcgRIII could be
confirmed with five different mouse IgG1 antibodies
(data not shown). The diminished phagocytosis of IgG1- RIII2/2 mice by trinitrophenol (TNP)-coatedSRBCs opso-
nized with 2.4G2 F(ab9)2 3 a-DNP F(ab9)2 bispecific anti-coated SRBCs was attributable to a defect in binding
as confirmed by EA rosette assays (data not shown), body revealed substantial phagocytosis (Figure 3B).
This indicates that FcgRII expressed on peritoneal mac-indicating that thioglycollate-elicited peritoneal macro-
phages bind IgG1-opsonized particles exclusively via rophages is capable of mediating phagocytosis, con-
firming earlier studies using transfected cell lines (JoinerFcgRIII.
Engagement of FcgRII on macrophages from Fcg- et al., 1990; Dae¨ron et al., 1993).
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Passive Cutaneous Anaphylaxis
In both FceRI2/2 (Dombrowicz et al., 1993) and FcR g
chain2/2 (Takai et al., 1994) mice, it has been shown that
IgE-mediated anaphylaxis depends on FceRI triggering
of effector cells, particularly mast cells. Observation of
IgE2/2 mice (Oettgen et al., 1994) suggested that not
only IgE but also IgG immune complexes are capable of
triggering anaphylaxis, confirming earlier observations
(Ovary et al., 1963). Moreover, the IgG-dependent ana-
phylaxis in these mice did not depend on complement
activation, suggesting a role for FcgR in the triggering
of effector cells, probably mast cells (Oettgen et al.,
1994). These observations, combined with our finding
that FcgRIII is crucial for IgG-mediated degranulation
of peritoneal mast cells in vitro, prompted us to assess
the contribution of FcgRIII in in vivo IgG-mediated pas-Figure 3. Phagocytosis of IgG-Opsonized Erythrocytes
sive cutaneous anaphylaxis. Local dye extravazation,
Adherent thioglycollate-elicited peritoneal macrophages from wild-
upon local injection of IgG followed by intravenous anti-type (dotted bars) and FcgRIII2/2 (hatched bars) mice were incubated
genic challenge 2 hr later, was evaluated as a mea-with SRBCs opsonized with (A) murine IgG1, IgG2a, or IgG2b anti-
sure for anaphylaxis. Within 20 min after antigenic chal-SRBCs or (B) first coated with TNP and subsequently opsonized
with the bispecific antibody heteroaggregate 2.4G2 F(ab9)2 3 a-DNP lenge, wild-type littermates mounted an IgG-dependent
F(ab9)2. After 30 min incubation at 378C, extracellular erythrocytes passive cutaneous anaphylaxis reaction, whereas, in
were lysed by a hypotonic shock and the percentage of macro- marked contrast, FcgRIII2/2 mice did not (Figure 5). Local
phages that had ingested one or more erythrocytes was determined
injection of mouse IgE anti-DNP, followed by DNP–by light microscopy. Results are expressed as the mean 6 SEM of
human serum albumin challenge, however, resulted infour individual experiments.
a prompt anaphylactic response in both FcgRIII2/2 and
wild-type mice (data not shown).
Mast Cell Degranulation
In contrast with mast cells from wild-type littermates, Arthus Reaction
The role of FcgRIII in the inflammatory response to IgGperitoneal mast cells from FcgRIII2/2 mice failed to de-
granulate upon stimulation either with immune com- immune complexes and its pathophysiology was further
evaluated by performing reverse passive Arthus reac-plexes made of mouse IgG and antigen (Figure 4A) or
with 2.4G2 and mouse anti-rat immunoglobulin F(ab9)2 tions. Series of variousdoses of rabbitanti-chicken oval-
bumin (anti-OVA) IgG were injected intradermally and(Figure 4B). These data provide direct evidence that,
as suggested by previous in vitro transfection studies subsequently chicken ovalbumin (OVA) was injected in-
travenously. Extravazation, a hallmark of the induced(Dae¨ron et al., 1992), FcgRIII on peritoneal mast cells
mediates positive activation signals upon cross-linking, immunopathological cascade, was visualized by intra-
venously injected Evans blue. In wild-type littermates,whereas the other FcgR expressed on these cells,
FcgRII, does not. Degranulation in response to FceRI extravazation of the blue dye was observed within 3 hr
at sites containing 1 mg antibody or more (Figure 6, left).engagement by passive sensitization with mouse IgE
followed by challenge with goat anti-mouse immuno- In FcgRIII2/2 mice, extravazation varied from indistin-
guishable from that of wild-type mice to markedly atten-globulin was similar in mast cells from wild-type and
FcgRIII2/2 mice (Figure 4C), demonstrating that Fcg- uated (Figure 6, left). The proposed contribution of com-
plement in the initiation of the Arthus reaction (Colten,RIII2/2 mast cells are functionally intact.
Figure 4. Mast Cell Degranulation
Resident peritoneal cells were incubated for 5 min at 378C with preformed immune complexes made of (A) anti-ovalbumin mouse serum
diluted 1/50 and the indicated concentrations of ovalbumin, or (B) 25 mg/ml mouse anti-rat immunoglobulin F(ab9)2 fragments and the indicated
concentrations of 2.4G2 F(ab9)2. (C) Aliquots of mast cells were incubated overnight at 378C with a 1/10 dilution of cell-free culture supernatant
from mouse IgE-secreting hybridoma cells 2682I (Dae¨ron et al., 1993), washed, and challenged with 25 mg/ml goat anti-mouse immunoglobulin
F(ab9)2 antibody for 5 min at 378C. Results are expressed as the percentage of degranulated mast cells.
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Figure 5. IgG-Mediated Passive Cutaneous Anaphylaxis
Wild-type (right) and FcgRIII2/2 (left) mice were injected intradermally in the left ear with 20 mg of rabbit IgG anti-ovalbumin and (as a control)
with saline in the right ear. Two hours later, 500 mg ovalbumin in 1% Evans blue were intravenously injected. After 30 min, a positive anaphylactic
reaction was visualized by extravasation of the blue dye.
1994) was supported by our observation that the varia- demonstrated that mast cells constitute the crucial ef-
fector cell type in IgE-dependent anaphylaxis (Wershiltion in extravazation intensity in FcgRIII2/2 mice corre-
lated with fluctuation in serum complement levels. This et al., 1987). Degranulation of murine mast cells can be
triggered in vitro by complexed IgG or anti-FcgRII/IIIvariability of complement was most probably due to the
genetic background of the mice, which is determined by antibody 2.4G2 (Vaz and Prouvost-Danon, 1969; Dae¨ron
et al., 1992). Transfection studies in rat basophilic leuke-a mixture between C57BL/6 and 129 strains; hemolytic
complement levels of normal inbred C57BL/6 mice aver- mia cells showed that murine FcgRIII, butnot FcgRII,can
induce degranulation (Dae¨ron et al., 1992). Our resultsaged 38.5 6 7.3 U/ml (n 5 10), and inbred 129 mice
averaged120.3 6 19.1 (n 5 10). Therefore, we performed clearly demonstrate that both IgG-mediated mast cell
degranulation and passive cutaneous anaphylaxis areArthus reactions after complement depletion with cobra
venom factor (CVF). CVF treatment abrogated extrava- absent in FcgRIII2/2 mice, indicating that these pro-
cesses require the presence of FcgRIII. Recently, anzation completely in all FcgRIII2/2 mice, while not affect-
ing that in wild-type mice (Figure 6, right). These data FcgRII2/2 mouse has been described that exhibited an
enhanced IgG-mediated passive cutaneousanaphylaxissuggest that IgG immune complex–mediated Arthus re-
action can be induced via two independent pathways: (Takai et al., 1996), confirming the proposed down-regu-
latory effect of FcgRII in this process (Dae¨ron et al.,a complement-dependent and a complement-indepen-
dent one. The complement-independent pathway de- 1995b). It would be of great interest to establish the
physiological conditions that determine the balance be-pends exclusively on FcgRIII-mediated triggering of ef-
fector cells. tween activation and down-regulation by FcgRIII and
FcgRII, respectively, in IgG-mediated anaphylaxis.
Previous results with g chain2/2 mice, which lack func-Concluding Remarks
In the present study, we identified FcgRIII as the crucial tional FcgRI, FcgRIII, and FceRI, showed an impaired
IgG-mediated Arthus reaction (Sylvestre and Ravetch,receptor mediating IgG-dependent anaphylaxis. This re-
sult provides direct in vivo evidence for the activating 1994), strongly suggesting a role for FcgR. The effector
cell type remained to be identified; the most likely candi-role of FcRs in IgG-dependent anaphylaxis, which was
suggested by previous studies (Ovary et al., 1963; Oett- dates being mast cells (which express FcgRII and
FcgRIII), neutrophils, and macrophages (both of whichgen et al., 1994). Studies with mast cell–deficient mice
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Figure 6. Reverse Passive Arthus Reaction
Wild-type (1/1) and FcgRIII2/2 (2/2) mice were injected intradermally, from the bottom left to the upper right with 30, 10, 5, 3, 1, and 0 mg
of rabbit IgG anti-ovalbumin per site and immediately thereafter, intravenously, with 500 mg ovalbumin in 1% Evans blue. Left, untreated mice
(2CVF), the 2/2 mouse at the top being representative for mice with complement serum levels below detection level (i.e., <32 U/ml), while the
mouse at the bottom is representative for mice with significant complement serum levels (i.e., 32 U/ml or more) as determined by haemolysis
assay; right, mice that were treated with cobra venom factor (1CVF) 1 day before performing the Arthus reaction. Animals were killed 3 hr
after the intravenous injections and the injected sites were analyzed for extravazation of the blue dye.
SuperCos 1) and subcloned in pBluescript. The gene-targeting con-express FcgRI, FcgRII, and FcgRIII). FcgRIII2/2 mice en-
struct was generated by replacing a 4.8 kb StuI–KpnI fragment,abled us to identify FcgRIII as the dominant FcR trig-
containing both the ligand-binding EC2 domain and the transmem-gering the initial phase of the Arthus reaction. Since this
brane region (encoded by exon 4, and the 59end of exon 5, respec-
reaction was absent in complement-depleted FcgRIII2/2 tively), by the PGK–hygror cassette. Transfection, selection, and
mice, FcgRI, being expressed on macrophages and neu- screening were performed as described (Verbeek et al., 1995), ex-
trophils, most likely plays a minor role, if it plays any. cept that the selection medium contained 150 mg/ml hygromycin.
Clones bearing a targeted FcgRIII allele were identified by SouthernResults concerning phagocytosis by macrophages
blot analysis of EcoRI-digested genomic DNA using a 39 genomicunexpectedly revealed that FcgRIII is required for
probe that hybridized outside the region included within the tar-phagocytosis of IgG1-opsonized particles, but not for
geting vector. Hybridizing bands of 10 kb or 3.2 kb indicate theIgG2a- or IgG2b-opsonized particles. The physiological
presence of FcgRIII wild-type or FcgRIII mutant alleles, respectively.
importance of this finding has yet to be determined. It From 240 hygror clones isolated, 3 (1.25%) had aquired the hygror
may well be that some in vivo IgG1- but not IgG2a- insertion by homologous recombination. One clone was selected for
or IgG2b-dependent effector functions of the immune microinjection of day 3.5 C57BL/6 embryos. Male chimeric offspring
were bred with C57BL/6 females and the tail DNA of agouti offspringsystem are largely mediated by FcgRIII.
analyzed for the presence of the mutated allele. Correct 59 integra-Identification of the FcR mediating anaphylactic and
tion was confirmed by hybridization of StuI-digested tail DNA withinflammatory processes is of crucial importance for the
a 59 flanking genomic probe.potential use of these receptors as a therapeutic target
for the control of immunopathological events. The pres-
ent study demonstrates that FcgRIII2/2 mice provide a Antibodies
useful tool to dissect the role of FcgRIII in various normal The following antibodies were used: 2.4G2 (Unkeless, 1979), which
and pathological immunological events. is directed against FcgRII/III (Pharmingen, San Diego, California);
M1/70 against Mac-1 (Boehringer Mannheim, Federal Republic of
Germany); RA3–6B2 against B220 (Coffman, 1982); 4D11 againstExperimental Procedures
LGL-1 (Mason et al., 1988) (provided by Dr. L. Mason); Sp3HL (mouse
IgG1) against SRBCs (Sera-Lab, Sussex, England); SS-1 (mouseGeneration of the FcgRIII-Deficient Mice
IgG2a) against SRBCs (American Tissue Culture Collection, Rock-A genomic clone that included 36 kb spanning the complete FcgRIII
locus was isolated from a strain 129 cosmid library (Stratagene ville, Maryland); Sp2/HL (mouse IgG2b) against SRBCs (Sera-Lab);
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mouse anti-rat IgG (Jackson, West Grove, Pennsylvania); polyclonal ADCC, the NK effector cells were preincubated with 2.4G2 hybrid-
oma supernatant.rabbit anti-ovalbumin (Cappel). The polyvalent R anti-ML1210 anti-
serum was prepared by injecting 6-month-old Chinchilla bastard
rabbits (Charles River, Federal Republic of Germany) subcutane- Phagocytosis of IgG-Coated SRBCs by Macrophages
ously with 4 3 107 L1210 tumor cells in complete Freund’s adjuvant SRBCs werewashed three times with ice-cold PBS by centrifugation
three times a week; in the fourth week the animals were bled and for 5 min at 1600 rpm and 48C. Next, 1% (v/v) dilutions of pelleted
the antiserum prepared according to standard procedures. The bi- SRBCs in RPMI containing 10% FCS were incubated with murine
specific antibody heteroaggregate composed of 2.4G2 F(ab9)2 frag- anti-SRBC MAbs of each of the IgG subclasses at various dilutions
ments and rabbit anti-DNP F(ab9)2 fragments, referred to as 2.4G2 for 30 min at 378C. The SRBCs were washed three times with PBS
F(ab9)2 3 a-DNP F(ab9)2, was provided by Dr. D. Segal, Bethesda, and suspended in RPMI containing 10% FCS before use. For some
Maryland. experiments, SRBCs were first conjugated with TNP by incubation
for 15 min at room temperature with 3.6 mg TNBS/ml of 0.28 M
cacodylate buffer (pH 6.9). These TNP-conjugated SRBCs were thenPreparation of NK Cell Suspensions
opsonized with thebispecific antibody 2.4G2 F(ab9)2 3 a-DNPF(ab9)2Fresh spleens from FcgRIII1/1 and FcgRIII2/2 littermates (4–6 weeks
as described above.old) were minced and mashed through a sieve yielding single cell
Peritoneal cells of mice, which had been injected intraperitoneallysuspensions of splenocytes. The lymphocyte fractions were isolated
with 1 ml of 0.5% thioglycolate (Difco Laboratories, Detroit, Michi-from a Ficoll gradient (Biochrom, Federal Republic of Germany) and
gan) 3 or 4 days before, were suspended in RPMI containing 10%depleted of B cells by a 1 hr incubation on a nylon-wool column. A
FCS. Next, the cells were incubated for 3 hr at 378C in 96-well tissuefurther enrichmentof NK cells was achieved by culturing for 5–7 days
culture plate (Nunc, Roskilde, Denmark) at a concentration of 5 3inculture medium supplementedwith 50 mM 2-mercaptoethanol and
103 cells perwell. After two washes with PBS to remove nonadherent500 U IL-2/ml.
cells, aliquots of 50 ml of 1% pelleted opsonized SRBC were added
to each well, and the plates were incubated for 30 min at 378C.RT–PCR with NK Cell–Derived RNA
Extracellular erythrocyteswere lysed by a hypotonic shock, immedi-Total RNA was prepared from NK cells from FcgRIII1/1, FcgRIII1/2,
ately followed by two washes with PBS. The percentage of positiveand FcgRIII2/2 littermates through the addition of guanidinium iso-
cells (i.e., those containing one or more erythrocytes) in each samplethiocyanate, followed by ultracentrifugation on a CsCl gradient. A
was determined by light microscopy.Hot Start RT–PCR protocol was used in a thermocycler Varius VR
(Landgraf, Hannover, Federal Republic of Germany). Of the total
Mast Cell DegranulationRNAfrom NK cells of wild-type and FcgRIII2/2 mice, 1 mg was reverse
Resident peritoneal cells were incubated with immune complexestranscribed by using cloned AMV reverse transcriptase (Promega).
prepared of 50 times diluted mouse anti-ovalbumin serum with vari-RNA from NK cell fractions was analyzed by RT–PCR using the
ous concentrations of ovalbumin, or of various concentrations ofsense primers S1s (59-ATGTTTCAGAATGCACACTCTGG-39, exon
2.4G2 F(ab9)2 with 25 mg/ml mouse anti-rat immunoglobulin F(ab9)2S1) and EC1s (59-TTCCAAAGGTGTGGTCA-39, exon EC1), and the
for 5 min at 378C. Alternatively, peritoneal cells were incubatedthree distinct antisense primers EC1as (59-CAGAAATCACTCTCAG
overnight at 378C with 10 times diluted cell-free supernatant fromATC-39, exon EC1), EC2as (59-GCTTGGACAGTGATGGTGAC-39,
mouse IgE-secreting hybridoma cells 2682I (Dae¨ron et al., 1993),exon EC2), and 3UTas (59-TCACTTGTCTTGAGGAGCCTGG-39, exon
washed, and challenged with 25 mg/ml goat anti-mouse immuno-TM/C/3UT). Hot Start PCR for amplification of the cDNA pools was
globulin F(ab9)2 for 5 min at 378C. Reactions were stopped at 08C,started using the primers after a denaturing step for 5 min at 948C
cells were stained with toluidine blue, and degranulation of mastwith the addition of 2 U Taq polymerase (Promega). We performed
cells was assessed microscopically as described (Dae¨ron et al.,30 cycles, each including a 30 s denaturing step at 948C, a 30 s
1993).annealing step at 588C, a 40 s extention step at 728C, followed by
a final 10 min extention at 728C. The PCR products were analyzed
on a 1.5% agarose gel visualized by ethidium bromide staining. Passive Cutaneous Anaphylaxis
Mice were injected intradermally in the ear with 25 ml containing 20
mg of rabbit IgG anti-ovalbumin or saline, and 2 hr later an intrave-Phenotype Analysis by Flow Cytometry
nous injection with 100 ml of a solution containing 500 mg of oval-Cells harvested from different organs of the mice were washed three
bumin and 1% Evans blue was given. About 30 min later, extravaza-times with RPMI 1640 medium and suspended at a concentration
tion was visualized by blue staining of the ear as an indication forof 2 3 105 cells/ml of phosphate-buffered saline (PBS) containing
a positive anaphylactic response. Replacing rabbit anti-ovalbumin2.5% fetal calf serum (FCS) and 0.05% sodium azide before use. The
with normal rabbit IgG, or of ovalbumin and Evans blue with Evanscell suspensions were incubated for 30 min on ice with monoclonal
blue only did not induce a reaction (data not shown).antibodies (MAbs) against cell surface molecules in PBS containing
2.5% FCS, and washed three times with the same buffer. After using
biotin-conjugated MAb, the cells were incubated with phycoer- Arthus Reaction
ythrin-conjugated streptavidin (Becton Dickinson, San Jose, Califor- Mice were injected intradermally at the basolateral side with 25 ml
nia) for 30 min on ice; after using unconjugated MAb, the cells were containing varying amounts of rabbit IgG anti-ovalbumin (ranging
incubated with fluorescein isothiocyanate–conjugated mouse anti- from 1–30 mg per site), and immediately thereafter intravenously
rat IgG for 30 min on ice, followed by three washes; these steps with 100 ml containing 500 mg ovalbumin in 1% Evans blue. The
were omitted when MAb were directly conjugated with fluorescein mice were killed 3 hr later and the injection sites at the reverse side
isothiocyanate, phycoerythrin, orCy-5. The fluorescence of the cells of skin sections analyzed for extravazation of the blue dye. In some
was examined using a FACScan (Becton Dickinson). experiments, mice were twice injected intraperitoneally with 150 U
cobra venom factor at 8 hr intervals the previous day in order to
inactivate complement. We used the assay described by Van DijkADCC and Natural Killer Activity by NK Cells
et al. (1980) to determine serum complement levels. In brief, rabbitCytotoxicity assays were performed using V-bottomed microtiter
erythrocytes, precoated with mouse anti-rabbit serum, were incu-plateswith 5,000 51Cr-labeled target cells at various effector to target
bated with various dilutions of fresh mouse serum for 1 hr at 308C;(E:T) ratios. Release of 51Cr into the supernatant was measured after
intact erythrocytes were spun down; and the extinction of the super-4 hr at 378C. Maximal release was determined by addition of 1%
natants at 405 nm, serving as a measure for hemolysis, was as-Triton-X 100 (Sigma). Spontaneous release was <10%. Specific cy-
sessed.totoxicity was calculated according to a standard method and all
values are given as the mean of triplicates (SD < 5%). The NK-
susceptible target cell YAC-1 was used for determination of natural Acknowledgments
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